Chemistry and the Economy: The Brexit, Challenges of Over-Supply and the End of Bank Stimulus
July 21, 2016 @ 2:00pm ET
The UK’s decision to leave the European Union (Brexit) is causing major upheaval in financial markets as investors rush to supposedly “safe havens”. This is highlighting the underlying slowdown in demand growth caused by globally ageing populations. What does this mean for the chemical and pharma industry? Can we still rely on the supply-driven strategies of the past? Or do we need to reinvent our business and investment strategies? Join Paul Hodges of International eChem and former Chair of the ACS Board William Carroll as they return to share an update on the factors affecting the market and what these mean for you.
What You Will Learn
- The likely impact of Brexit on US and global financial markets
- The outlook for demand now the stimulus programs have ended
- Opportunities for growth in the New Normal world
- Bruises from Brexit start to show in U.K. chemistry enterprise - Article by c&en's Alex Scott, Senior Editor for Europe
- UK scientists dropped from EU projects because of post-Brexit funding fears - Article by The Guardian
- What Can the U.K. Stock Market Tell You About Brexit? - Article and short video by Bloomberg
- U.K. chemistry enterprise feels ‘Brexit’ pain - Article by c&en
- Chemistry & the Economy Webinar Series - Past ACS Webinars with Paul Hodges
The Fine Print
ACS Webinars® does not endorse any products or services. The views expressed in this presentation are those of the presenters and do not necessarily reflect the views or policies of the American Chemical Society.